Company: BCAR
Filing Date: 2025-06-30
Form Type: S-1/A
Source: 0001829126-25-004773
Chunk: 132

Company: D. Boral ARC Acquisition I Corp.
Filing Date: 2025-06-30
Form: S-1/A
Chunk 132
---
 or the NYSE, they may reject our listing application, and the parties may waive any closing condition in the initial business combination agreement that ordinary shares of New ARC be listed on Nasdaq or the NYSE at the closing of the initial business combination.

Following our initial business combination, we expect that the ordinary shares and public warrants of New ARC will be listed on either Nasdaq or the New York Stock Exchange (“NYSE”). To list these securities on Nasdaq or the NYSE, New ARC will be required to comply with initial listing requirements, including the minimum market capitalization standard, the corporate governance requirements and the minimum closing bid price requirement, among other requirements. In the event that New ARC fails to satisfy any of the listing requirements, Nasdaq or NYSE may reject New ARC’s listing application. Though the listing of New ARC’s ordinary shares on either Nasdaq or NYSE is expected to be a condition to the closing of our initial business combination, the parties may waive such closing condition and proceed to close, in which case the New ARC’s ordinary shares will likely instead be quoted on the OTC Markets. If the New ARC’s ordinary shares are not listed on Nasdaq or NYSE, it is likely to be more difficult to trade in or obtain accurate quotations as to the market price of the New ARC’s ordinary shares. As a result, New ARC could face significant adverse consequences. Please see “Risk Factor – Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.”

Our initial shareholders paid an aggregate of $25,000, or approximately $0.002 per founder share and, accordingly, you will experience immediate and substantial dilution from the purchase of our Class A ordinary shares.

The difference between the public offering price per share (allocating all of the unit purchase price to the Class A ordinary share and none to the warrant included in the unit) and the pro forma net tangible book value per share of our Class A ordinary shares after this offering constitutes the dilution to you and the other investors in this offering. Our initial shareholders acquired the founder shares at a nominal price, significantly contributing to this dilution. Upon closing of this offering, and assuming no value is ascribed to the warrants included in the units, you and the other public shareholders will incur an immediate and substantial dilution of approximately 99.1% (or $9.91 per share, assuming no exercise of the underwriters’ over-allotment option),